2021 January 21
The Josep Carreras Leukemia Institute opens a new lab devoted to cellular systems genomics
Elisabetta Mereu joins the Josep Carreras Institute to head the Cellular Systems Genomics laboratory.
News
2021 January 18
New epigenetic targets identified for the potential treatment of multiple myeloma
Researchers at the Josep Carreras Leukaemia Research Institute have identified epigenetic alterations in multiple myeloma and have tested a compound that reverse those alterations, opening the door to a new therapeutic drug in the treatment of multiple myeloma
2021 January 11
The INTERCEPT-MDS PhD fellowships to train Europe’s first experts in the emerging field of disease interception are open for applications.
Three of the twelve positions at the forefront of research into myeloid diseases will be based at the Josep Carreras Leukaemia Research Institute as part of the Innovative Training Network (ITN) entitled INTERCEPT-MDS. The Josep Carreras Institute coordinates this Marie Skłodowska Curie Action funded by the European Commission under the H2020 framework.
2020 December 31
Researchers from the Josep Carreras Institute received one of the five grants awarded worldwide by the Facebook founder’s Foundation to study COVID-19
The epigenetics and immune diseases group, led by Dr Esteban Ballestar, obtained one of the five worldwide grants awarded by the Chan Zuckerberg Initiative.
2020 December 16
Cancer cells resistant to treatment are already present before diagnosis of adult leukaemia
Dr. Josep Maria Ribera and Dr. Eulalia Genescà collaborate in this study, published in Genome Biology, with Núria López-Bigas’lab at IRB Barcelona and the group headed by Anna Bigas at Hospital del Mar Medical Research Institute.
2020 December 10
Discovered a new prognostic marker in a specific subtype of acute lymphoblastic leukemia (ALL) with adverse outcome in infants
The “Lymphocyte Development and Disease” group, from Josep Carreras Leukaemia Research Institute, led by Dr. Maribel Parra, has recently published a new paper in Leukemia journal, describing HDAC7 protein as a prognostic marker of this specific subtype of infant ALL
2020 November 30
Discovered the explanation of the patients with “lazarus-like” cancer
An article published in Cancer Cell with the collaboration of the group of Dr. Manel Esteller, Director of the Josep Carreras Leukemia Research Institute (IJC), ICREA Research Professor and Professor of Genetics at the University of Barcelona, today provides us with the reasons that would explain the extraordinary response of these individuals to cancer therapy.
2020 November 26
Seven investigators of the Josep Carreras Institute are recognized between the researchers with the most impact on world level.
Seven investigators of the Josep Carreras Leukemia Research Institute are recognized by the prestigious Stanford University in the United States among the researchers with the most impact on world level.
2020 November 25
Dr. Marcus Buschbeck leads the European Network INTERCEPT-MDS focusing on the shared training and research in Myeloid Diseases.
Dr. Marcus Buschbeck, group leader of the Josep Carreras Leukaemia Research Institute, coordinates the Innovative Training Network (ITN) INTERCEPT-MDS, a Marie Skłodowska Curie Action, funded by the European Commission under H2020 framework programme.
2020 November 18
Manel Esteller is referred as Highly Cited Researcher According to 2020 Web of Science Group List
Josep Carreras Leukaemia Research Institute director Manel Esteller has been named Highly Cited Researcher, according to the Highly Cited Researchers 2020 list from the Web of Science Group, released today.
